Introduction
Ischemia of tissues during arterial occlusion, shock and organ transplantation is a common and important cause of cell death. Aected tissues exhibit profound losses of adenosine triphosphate (ATP), which trigger multifarious degenerative processes. Declines of ATP depend not only on hypoxia and attendant cessation of oxidative phosphorylation, but also on failure of anaerobic glycolysis. For this reason, ischemic cell damage is more severe and proceeds faster than hypoxic injury under conditions which permit anaerobic glycolysis.
Cells may die during ischemia itself, in which case, early membrane damage leads to activation of multiple degradative systems in an uncontrolled fashion. This form of death is necrotic; dead cells are found in the cores of ischemic regions, but may also be diusely distributed if the ischemic period is relieved by reperfusion of blood. Of much clinical and scienti®c interest is the additional loss of parenchymal cells that occurs during reperfusion following ischemia. Sublethal ischemic damage may cause some cells to undergò reperfusion injury' when reoxygenated by blood re¯ow. Because availability of oxygen and nutrients during reperfusion allows ischemic cells to restore ATP pools, additional losses of cells during reperfusion could be apoptotic, since this form of cell death requires energy (Eguchi et al., 1997; . There have been reports of reperfusion injury by apoptosis, and several mechanisms have been proposed (Piper et al., 1998; MacLellan and Schneider, 1997; Chopp and Li, 1996) . However, there is controversy whether necrosis and apoptosis are uniquely dierent with respect to pathogenetic mechanisms, and if they can be reliably distinguished. Also, there is uncertainty with respect to death of parenchymal cells caused by ischemia and reperfusion per se, relative to cell death caused secondarily by in¯ammation in the infarct. In fact, if the identity of dead cells is not established by morphology or cellular markers, it is dicult to know if the aected cells are parenchymal, endothelial or in¯ammatory. This diculty is compounded in studies of the central nervous system, which exhibits intimate intermingling of glial cells and neurons. Under these conditions it is dicult to assess if pharmacological agents, including caspase inhibitors, ameliorate ischemic injury by decreasing in¯ammation or by inhibiting damage mechanisms speci®c to parenchymal cells. Such cell speci®c injury pathways are more easily identi®ed by subjecting puri®ed cells or cell cultures to hypoxia and substrate deprivation in order to simulate ischemia.
Factors that may determine expression of cell death as apoptosis or necrosis
Apoptosis and necrosis were originally described to be two distinct forms of cell death, that can be clearly distinguished (Wyllie, 1994) . However, these two types of cellular demise can occur simultaneously in tissues or cultured cells exposed to ischemia-hypoxia and reoxygenation (Kato et al., 1997; Kajstura et al., 1998; Li et al., 1998a; Lieberthal and Levine, 1996; Noda et al., 1998; Weigele et al., 1998) . The intensity and duration of insults may decide the outcome (Bonfoco et al., 1995; .
Thus, in certain cases, triggering events can be common for both types of cell death. However, a downstream controller may be required to direct cells towards the organized execution of apoptosis. If the apoptotic program is aborted before this control point, and the initiating stimulus is severe, cell death may still result, by necrosis . Consistent with this view, caspase inhibition was sucient to prevent proteolysis and DNA fragmentation in Bax or drug induced apoptosis, but did not prevent plasma membrane damage and cell death (Xiang et al., 1996; Lemaire et al., 1998) . The inability of caspase inhibitors to confer long term viability under some circumstances of injury could be related to the involvement of mitochondrial factors in transducing apoptotic signals (McCarthy et al., 1997; .
Apoptotic processes may involve at least two dierent mechanisms initiated by distinct caspases. When death receptors are ligated, they recruit and proteolytically activate the initiator caspase-8 (Ashkenazi and ) that in turn triggers eector caspases. This cascade can be ampli®ed by caspase-8 mediated mitochondrial damage and release of apoptogenic factors (Luo et al., 1998; Li et al., 1998b) . Because the proximate trigger involves the initiator caspase, caspase inhibitors abort the entire death cascade and provide complete protection. However, other apoptotic stimuli lead to the activation of caspase-9 and require a proximate trigger that involves increased mitochondrial permeability mediated by the mitochondrial permeability transition and/or release of cytochrome c (Zhou et al., 1997; Li et al., 1997) . Whereas anti-apoptotic members of the Bcl-2 family can abort the death cascade by preventing mitochondrial damage (Yang et al., 1997; Kluck et al., 1997) , caspase inhibitors have the power only to prevent structural damage caused by downstream execution events. Because they cannot prevent irreparable mitochondrial damage, cell death is assured (Xiang et al., 1996; McCarthy et al., 1997; Miller et al., 1997; Saikumar et al., 1998) , and may be expressed as necrosis.
Biochemical overlaps between apoptosis and necrosis
Identi®cation of apoptotic and necrotic death processes requires more rigorous methodology than has been generally used (McCarthy and Evan, 1998) . Artifacts inherent in techniques that detect breaks in double stranded DNA as well as overlaps between apoptotic and necrotic death programs account for these problems (McCarthy and Evan, 1998) . Internucleosomal DNA cleavage and false positive TUNEL staining of nuclei are readily induced in tissues even by short delays in tissue preparation (McCarthy and Evan, 1998) . These methodological considerations are relevant to ischemically injured tissues; the necrotic mode of cell death is abundantly expressed during ischemic injury, and the nature of the pathology makes tissue preparation prone to artifacts. Recent studies on ATP depletion induced by chemical hypoxia show that there are overlapping patterns of nuclear breakdown and DNA cleavage between apoptotic and necrotic death programs. Internucleosomal cleavage of DNA in multiples of 180 bp occurs during necrosis soon after the development of increased plasma membrane permeability, in a`ladder' pattern, indistinguishable from that seen in apoptosis (Dong et al., 1997;  see Figure 1 ). The serine protease inhibitor TPCK, but not the caspase inhibitors Z-VAD-fmk and Z-DEVD-fmk inhibited DNA ladders (Figure 1a) . Moreover, DNA ladders and caspase activation could be dissociated during fas mediated apoptosis of Jurkat cells ( Figure  1b) . In another study, increases of Ca 2+ in chemically hypoxic cells led to nuclear condensation, hydrolysis of lamins A and C and DNA cleavage into large 50 ± 150 kb fragments indistinguishable from those seen in the early stages of apoptosis; with the onset of plasma membrane damage, typical DNA ladders also formed . These considerations underscore the need for caution when the relative contributions of necrotic and apoptotic programs in ischemic or hypoxic cell death are evaluated.
Cell death in ischemia-hypoxia followed by reoxygenation
The apoptotic process of cell death is divided into three phases: the initiator or induction phase, which depends on speci®c death-inducing signals, the eector phase, in which an execution mechanism is activated, and the degradation phase, during which cells show morphological and biochemical features of apoptosis. What is the nature of the initiating mechanism that could lead to apoptosis during reoxygenation injury? Several possibilities need to be considered. First, it has been reported that expression of Fas ligand during hypoxia/reoxygenation may trigger Fas dependent death pathways (Matsuyama et al., 1995; Nogae et al., 1998; Vogt et al., 1998) . In some models it has been shown that inhibition of caspase-1 (interleukin-1b-convertase; ICE) conferred neuronal protection (Hara et al., 1997) . ICE activates pro-IL-1b to generate mature IL-1b, and this proin¯ammatory cytokine is also a mediator of ischemic injury. These results are further supported by the observation that mutant mice de®cient in the ICE gene are less severely injured by brain focal ischemia as compared with wild-type controls (Schielke et al.,1998) . How IL-1b induces ischemic injury is still unclear.
Second, reoxygenation injury has been attributed to the toxic eects of oxygen free radicals generated during reperfusion of organs with oxygenated blood (McCord, 1985) . Ample evidence exists for the overproduction of radicals in reperfused organs (Chan, 1994; Flitter, 1993; Gonzalez-Flecha and Boveris, 1995; Johnson and Weinberg, 1993) , but following an initial increase, cellular concentrations are buered sharply down by endogenous antioxidants (Flitter, 1993; Gonzalez-Flecha and Boveris, 1995) . It is also well known that invading in¯ammatory cells add an element of oxidant damage to reperfusion injury that may take place by other mechanisms (Engler, 1989; Granger, 1988; Thiagarajan et al., 1997) . Nonetheless, it is not known whether the production of oxygen radicals in parenchymal cells of reoxygenated organs is the cause or result of injury.
A third possibility for which substantial support exists, is that irreparable mitochondrial damage underlies cell death by hypoxia/reoxygenation. Since mammalian cells are obligately dependent on mitochondria for long term viability, it follows that irreversible mitochondrial damage should have lethal consequences. This may happen in several ways. Electron conduction defects have been demonstrated to occur in ischemic and hypoxic cells (Piper et al., 1994) , and if the defects are not corrected during reoxygenation, a lethal outcome is certain since any capacity for anaerobic glycolysis that the aected cells may have will eventually be compromised by mitochondrial dysfunction. Other factors, discussed below, are mitochondrially generated oxygen free radicals, inner membrane permeability defects termed mitochondrial permeability transitions (MPT) and the release of apoptogenic factors from mitochondria induced by pro-apoptotic members of the Bcl-2 family of proteins.
Are oxygen radicals involved in apoptosis associated with reoxygenation?
Oxygen free radicals have been implicated in the pathogenesis of reperfusion injury (McCord, 1985) . However, it is probable that the free radicals are derived from in®ltrating leukocytes in aected tissues Figure 1 Eect of protease inhibitors on internucleosomal DNA cleavage during Apoptosis (a) and necrosis (b). (a) After 20 min preincubation without or with caspase inhibitors z-VAD-fmk (VAD; 10 mM); z-DEVD-fmk (DEVD; 14 mM), or with serine protease inhibitors 3,4-dichloroisocoumarin (DCI; 100 mM), phenylmethane sulphonyl¯uoride (PMSF; 1 mM), tosyl phenylalanyl chloromethyl ketone (TPCK; 100 mM) or with the cysteine protease inhibitor iodoacetic acid (IAA; 1 mM) 100 ng/ml Fas antibody was added to Jurkat cells for 5 h to induce apoptosis. Caspase activity was blocked in cells treated with -SH reactive agent IAA (not shown), but these cells developed early membrane damage, and typical DNA ladders neverthless. (b) Necrosis was induced in MDCK cells by incubating with 0.2 mg/ml saponin. Cell lysis was indicated as % of lactate dehydrogenase released (free LDH) and shown at the top of each lane. DNA fragments were analysed by gel electrophoresis. Identical patterns of DNA cleavage were seen in necrosis induced by ATP depletion (adopted from Dong et al., 1997) rather than parenchymal cells per se (Cotran et al., 1998) . To examine whether oxidant stress is involved in triggering apoptosis during reoxygenation, we employed a model of reoxygenation injury in cultured rat kidney proximal tubule cells (RPTC; . RPTC were subjected to hypoxia for 5 h without glucose, and were then returned to either normoxic complete growth medium or oxygen-free complete growth medium that had been equilibrated with 95% N 2 and 5% CO 2 . Incubation of hypoxic cells in O 2 -free medium led to 42% cell death after 2 h (Figure 2a , 5H/2R: N 2 ), which was not dierent from values observed in cells returned to normoxic medium (44%; Figure 2a , 5H/2R: N/A), excluding oxygen or free radicals derived therefrom as death triggers. These results agree with earlier reports that apoptosis can be induced without the involvement of oxygen free radicals (Shimizu et al., 1995; Jacobson and Ra, 1995) and were further substantiated by the failure of N-acetyl-cysteine (NAC; 1 ± 10 mM), a chemical antioxidant (Sundaresan et al., 1995) and Mn(III) tetrakis(4-benzoic acid) porphyrin chloride (MnTBAP; 10 ± 100 mM), a cell permeant superoxide dismutase mimetic (Faulkner et al., 1994) , to aect cell death during reoxygenation (Figure 2a ; shown for 1 mM NAC, 100 mM MnTBAP). Production of oxygen free radicals was measured as the oxidation of dihydrodichloro¯uorescein (H2-DCF) to generate the fluorescent compound DCF . The relative DCF¯uorescence with NAC was less, indicating that reactive oxygen species were being scavenged, while MnTBAP increased the signal, consistent with accelerated dismutation of superoxide and production of hydrogen peroxide (Figure 2b ). However, with or without the drugs, DCF¯uorescence during reoxygenation was less, not more, than in control cells that had not been subjected to hypoxia (Figure 2b ). This is consistent with the demonstration that reoxygenation of hypoxic kidney proximal tubules results in decreased rather than increased oxidant stress (Zager, 1993) .
Loss of mitochondrial cytochrome C during ischemia-hypoxia
Loss of cytochrome c may be one reason for respiratory dysfunction in post-ischemic-hypoxic mitochondria (Piper et al., 1994; Borutaite et al., 1996; Naro et al., 1993) . In support, electron transport was restored by the addition of exogenous cytochrome c to mitochondria isolated from ischemic hearts (Borutaite et al., 1996; Mur®tt et al., 1978; Toleikis et al., 1980) . More recently, studies of hypoxia/reoxygenation injury in cultured proximal tubule cells of rat kidney have documented evidence for mitochondrial damage during hypoxia by a process that led to complete loss by diusion of cytochrome c into the cytosol.
Mechanisms of mitochondrial cytochrome C release

Mitochondrial permeability transition (MPT)
Evidence for the occurrence of the MPT in cells injured by ischemia or hypoxia has been obtained from studies on organs subjected to ischemia/reperfusion, parench- H-thymidine, were subjected to 5 h of hypoxia followed by 2 h of incubation in full growth medium (5H/2R) under anaerobic conditions (N2) or aerobic conditions without any agents (N/A), or with 100 mM Carbobenzoxy-Val-Ala-Asp-¯uoromethyl ketone (VAD), or 1 mM N-acetylcysteine, an anti-oxidant, (NAC), or 100 mM Mn(III)tetrakis(4-benzoic acid) porphyrin chloride (Calbiochem-Novabiochem Co., CA, USA), a superoxide dismutase mimetic (MnTBAP). Control cells (CON) received no treatment. For anaerobic incubation, the culture medium was preequilibrated with 95% N 2 /5% CO 2 for 48 h. To ensure lack of O 2 , EC Oxyrase (Oxyrase Inc., OH, USA), an oxygen scavenging enzyme preparation, was present for the last 2 h of pre-equilibration. DNA fragmentation was analysed as described (Dong et al., 1997) . (b) Reactive oxygen species within cells were measured by the oxidization of 2',7'-dichlorodihydro¯uorescein diacetate (H2-DCF) to generate the¯uorescent product, dichloro¯uorescein (DCF; Sundaresan et al., 1995) . Cells were loaded with H2-DCF (10 mM) for 30 min under normoxic conditions or during the last period of hypoxic incubation. Control cell: cells that received no treatment. Reoxygenated cell: cells made hypoxic for 5 h and reoxygenated. Both groups of cells were transferred to normoxic Krebs ± Ringer buer (KRB) containing 17.5 mM glucose in the absence (N/A) or presence of 1 mM N-acetylcysteine (NAC) or 100 mM MnTBAP (MnTBAP). DCF¯uorescence (Ex 480 nm/Em 520 nm) during 60 min of KRB incubation was recorded. Similar results were obtained with NAC at 1 or 10 mM and with MnTBAP at 10 or 100 mM (not shown). Values are means+SE (n=4). Data shown here are our unpublished results ymal cells isolated after hypoxia/reoxygenation, and mitochondria isolated from ischemic tissues (Lemasters et al., 1998; Piper et al., 1994) . Although the development and pathological signi®cance of the MPT has been rigorously documented by in vitro studies, extrapolation of these results to pathogenetic events during ischemic injury in vivo, or even hypoxic injury of whole isolated cells in vitro, has been fraught with diculties. This has been largely due to the simultaneous occurrence of several destructive processes during cell damage by ATP depletion and the lack of interventions which have sucient power to discriminate between events that are causal, and those which evolve secondarily as eects. Current hypotheses regarding the role of MPT in ischemic hypoxic damage center around ATP depletion related increases of ionized calcium, which induce hyperpermeability of the inner mitochondrial membrane to solutes in a nonselective manner. This`mitochondrial permeability transition' or MPT behaves like a membrane pore which allows diusion of solutes 51 500 daltons in size. Its formation is thought to be mediated by improper interactions between proteins in a multiprotein complex centered on the adenine nucleotide translocase, a mitochondrial cyclophilin, adenylate kinase and porin, located in`focal contacts' between inner and outer mitochondrial membranes (Frade and Michaelidis, 1997). Although it can occur as a temporary event, the MPT can rapidly become irreversible, with resulting loss of mitochondrial homeostasis, and cause high amplitude mitochondrial swelling. Since the inner membrane has a larger surface area than the outer membrane, mitochondrial swelling can cause rupture of the outer membrane, releasing intermembrane proteins into the cytosol (Petit et al., 1998; Reed et al., 1998) . There have been several reports to the eect that cyclosporin A, a drug that binds mitochondrial cyclophilin, prevents the MPT and ameliorates reoxygenation injury (Halestrap et al., 1997) .
Role of Bax
Members of the Bcl-2 family of proteins associate with mitochondrial membranes and regulate mitochondrial pathophysiology. Bcl-2, the prototype anti-apoptotic protein, inhibits MPT in some models of apoptosis and thus prevents the release of apoptogenic factors such as cytochrome c and apoptosis inducing factor (AIF) from mitochondria into the cytosol (Susin et al., 1996; Kluck et al., 1997) . Overexpression of Bax, a proapoptotic protein of the Bcl-2 family, results in loss of mitochondrial potential (Dc), induction of MPT and release of cytochrome c into the cytosol (Pastorino et al., 1998) . However, it remained unclear whether MPT and loss of Dc were the cause or result of apoptotic events, since these mitochondrial end-points might have been measured in cells that were moribund or post-mortem. Recently, we have shown that Bax is translocated from cytosol to mitochondria during ATP depletion caused by hypoxia or inhibition of oxidative phosphorylation by an uncoupler, causing the release of cytochrome c from mitochondria into the cytosol . Although the mechanisms by which Bax promotes cytochrome c release are still unclear, these studies of cultured proximal tubule cells demonstrated for the ®rst time that Bax translocation can take place under ATP depleted conditions, suggesting that the hypoxic model will provide new clues in identifying the mechanisms by which Bax is normally retained in the cytosol despite having mitochondria targeting signals in its carboxy terminus.
Our studies have shown that under conditions of hypoxia, Bax induced cytochrome c release is unlikely to be due to the induction of MPT. The mechanism by which MPT are thought to induce cytochrome c release involves loss of the normal inner membrane barrier to small solutes leading to matrix swelling and rupture of outer membranes. This should result in irreversible damage to mitochondria. However, our results ( Figure  3) show that regeneration of ATP by glycolysis during reoxygenation is associated with recovery of mitochondrial potential in the same cell populations that had leaked cytochrome c during hypoxia. By demonstrating the ability of mitochondrial inner membranes to retain gradients of protons, these studies show that MPT, if they had occurred at all during hypoxia, must have been reversible. A more likely explanation for the release of cytochrome c from the mitochondrial intermembrane space is the formation of pores in mitochondrial outer membranes, mediated by the insertion of Bax, leaving the inner membranes intact. Studies of Bax induced cell death in other models support this hypothesis (Eskes et al., 1998; Jurgensmeier et al., 1998) .
Role of caspases in ischemia-hypoxia mediated injury
It has been reported earlier that caspases are involved in hypoxic or ischemic cell death (Shimizu et al., 1996; Cheng et al., 1998; Yaoita et al., 1998; Kaushal et al., 1998) . We have reported that DEVDase activity (mediated by caspase-3, a distal eector caspase) is increased dramatically during hypoxia or ATP depletion in a time dependent manner, concurrently with Bax translocation and cytochrome c release . However, Caspase-3 activation is not required for Bax translocation and cyt.c release, since neither process is prevented by caspase inhibition . The immediate proximate cause of caspase-3 activation during hypoxia or ATP depletion is unclear. Three mutually non-exclusive possibilities could account for the activation of caspase-3. First, released cyt.c, in conjunction with the cytosolic factors apaf-1 and caspase-9, may stimulate the conversion of procaspase-3 to active protease in presence of dATP/ ATP (Thornberry and Lazebnik, 1998; Li et al., 1997; Zhou et al., 1997; Pan et al., 1998) . Whether sucient dATP is still available during ATP depletion to trigger this mechanism is not known. Second, it has been reported that a novel apoptosis inducing factor (AIF) is released from mitochondria by agents that induce mitochondrial permeability transition (MPT; Kroemer et al., 1997; Susin et al., 1996) . AIF is reported to be released as a result of permeability transition (PT) pore opening (Susin et al., 1996) and may directly activate caspase-3. However, the nature of AIF is unknown, and its role in our model cannot be speculated upon. Third, increased DEVDase activity could be due to the release of mitochondriaassociated caspase-3 during hypoxia. Recently, a caspase-3 precursor was identi®ed to be present both in mitochondria and the cytosol (Mancini et al., 1998) . Although the precursor was lost from the mitochondria following apoptotic stimulation, it was not determined whether the precursor was activated in mitochondria and then released into the cytosol, or whether it was activated after release. Bcl-2 regulation is common to all these possible pathways of caspase-3 activation. While the mechanism of caspase-3 activation during hypoxia is likely to involve the formation of ternary complexes between cytochrome c, the protein Apaf-1 and the initiator caspase-9 (Li et al., 1997; Zhou et al., 1997; Pan et al., 1998) , the almost certain participation of these transducing events in hypoxic injury remains to be shown.
Although caspase-3 was activated during hypoxia, morphological alterations resembling apoptosis did not occur suggesting that ATP is required to eect apoptosis. The events that require ATP probably involve translocation of active caspase-3 to the cellular targets such as nuclei and other cytoplasmic structures. Mitochondrial translocation of Bid, another death agonist of the Bcl-2 family, requires caspase-8 activation (Luo et al., 1998; Li et al., 1998b) . Thus, Bid induced mitochondrial damage is contingent upon an initiator caspase trigger situated proximally in death-receptor mediated apoptotic pathways.
Based on our results ) and other information, we propose a model for Bax induced release of cytochrome c from mitochondria (Figure 4) . This model takes into account a mitochondrial membrane protein or protein complex to form protein-transporting pores by Bax. In this concept, Bcl-2 inhibits Bax pore formation by competing with a protein or protein complex.
ATP availability during reoxygenation determines death outcome
Cells injured by ischemia/reperfusion can display necrotic as well as apoptotic morphology (Kato et al., 1997; Kajstura et al., 1998; Li et al., 1998a; Wiegele et al., 1998; Lieberthal and Levine, 1996) . Apoptosis is an energy dependent process (Wyllie, 1994; Vaux and Strasser, 1996) . Impaired electron transport due to loss of mitochondrial cyt.c would prevent recovery of cellular ATP pools if anaerobic glycolysis is not feasible, and thus lead to death by caspase-independent processes due to prolonged ATP depletion. On the other hand, apoptosis will result if energy levels increase by virtue of glycolysis. Studies in cultured kidney cells showed that incubation of previously hypoxic cells in glucose free medium led to early plasma membrane damage and cell death with necrotic morphology . In sharp contrast, cells reoxygenated in presence of glucose showed characteristic apoptotic morphology. Cell death by necrosis during reoxygenation in glucose free medium was not suppressed by the caspase inhibitor VAD (100 mM) suggesting a caspase-independent process. Importantly, overexpression of Bcl-2 completely blocked cell death regardless of whether the death mechanisms were mediated by caspases or not . It was also shown that Bcl-2 preserved mitochondrial integrity during hypoxia and promoted ATP generation even in the absence of glucose, utilizing respiratory substrates during reoxygenation. Based on the studies available to date, we have proposed a general scheme for the evolution of cell death in the hypoxia and reoxygenation model of injury ( Figure 5 ). . Immediately after the rhodamine 123¯uorescence was recorded, cells were ®xed and immunostained for cytochrome c using CY3-conjugated secondary antibodies . Fluorescence microscopy of immunostained cells (a) show that the majority of cells released cytochrome c into their cytosol, although almost all cells were able to mount mitochondrial potential (b). Identical Fields showing the same cell population in which mitochondria that leaked cytochrome c into cytosol were able to upload rhodamine 123 are shown in the insets. These results clearly indicate that the Bax translocation we observed during hypoxia did not damage the mitochondrial inner membrane even after releasing cytochrome c. Data shown are our unpublished results
Figure 4
Model for Bax induced mitochondrial outer membrane permeability changes. Based on our results , we propose that Bax, a mitochondrially targeted protein, is retained in the cytosol by yet to be identi®ed tethering chaperones. During hypoxia, Bax is translocated to mitochondria. This results in cytochrome c release into the cytosol. Released cytochrome c can activate cytosolic caspases through Apaf-1, a CED-4 homolog. This model also postulates an outer membrane protein or protein complex to be involved in Bax mediated pore formation. Overexpressed Bcl-2 may compete for the associated protein or protein complex to inhibit Bax pore formation. This model also includes the possibility of an activated caspase molecule being released from Bax translocated mitochondria Figure 5 Evolution of cell death in the hypoxia and reoxygenation model of injury. Mitochondria release apoptogenic factors both by Bax mediated and Bax-independent pathways during ischemia-hypoxia. Bax independent mechanisms may involve membrane permeability transition (MPT) pore formation, which leads to mitochondrial swelling and rupture of outer membrane. Baxmediated pathways only aect outer membrane and release cytochrome c. If glycolysis prevails during reoxygenation of hypoxia damaged cells, glycolytic ATP drives cells to apoptotic form of death. In the absence of glycolytic ATP and lack of ATP production by defective mitochondria, cells devoid of ATP undergo necrosis
Conclusions
It is increasingly clear that mitochondria constitute an important component of the cell death machinery. Since mammalian cells are obligately dependent on mitochondrial function for long-term viability, irreversible mitochondrial damage during ischemia or hypoxia is certain to assure a lethal outcome. Much progress has been made in understanding how the ATP depletion which characterizes hypoxic insults leads to mitochondrial damage and how the damaged organelles may transduce downstream death pathways. Relevant abnormalities include mitochondrial electron transport defects, generation of oxygen free radicals, mitochondrial permeability transitions (MPT) and release of apoptogenic factors induced by death proteins of the Bcl-2 family. That irreversible blocks of electron transport have lethal signi®cance is intuitive, and such defects have been shown to occur in mitochondria isolated from ischemic organs. How these defects may lead to further steps in structured death pathways is not known. Increased generation of oxygen free radicals by damaged mitochondria has been considered to be an important pathogenetic factor in reoxygenation injury. However, we have been unable to detect such increases during reoxygenation following hypoxia of cultured renal cells, and could show unabated activation of apoptotic cascades even under oxygen free conditions, provided that recovering cells could synthesize ATP by anaerobic glycolysis. Development of irreversible MPT, a structurally disruptive event, is in itself a plausible predictor of cell death during reoxygenation injury, without need to invoke release of apoptogenic factors as its direct consequence. There is precedent for its occurrence as a terminal event during reoxygenation injury, and for its prevention by pharmacological intervention using the cyclophillin binding drug, cyclosporine A. However, using the hypoxia/reoxygenation model in cultured renal cells, we have shown that mitochondrial inner membrane retained its integrity as indicated by its ability to restrict proton permeability and maintain potential gradients during reoxygenation. On the other hand, depletion of ATP, associated with hypoxia, resulted in translocation of Bax from cytosol to mitochondria, and concurrent release of cytochrome c and activation of caspase-3. While the transducing mechanism responsible for caspase-3 activation remains to be identi®ed, the results strongly suggest that Bax translocation is a determining pathogenetic event, and that Bax permeabilizes the mitochondrial outer membranes. It seems likely that translocated Bax does not require MPT in order to eect cytochrome c release. Other results using the same injury model showed that Bcl-2 does not antagonize Bax translocation during hypoxia, but prevents mitochondrial release of cytochrome c and aborts all downstream death events. Thus, Bcl-2 not only inhibits apoptosis, but, by maintaining the integrity of the electron transport chain and promoting oxidative phosphorylation, also can prevent necrosis that may otherwise aect cells with glycolytic disability. An important clinical consideration that follows from these results is that caspase inhibitors cannot oer long-term protection to ischemically injured parenchymal cells regardless of how eectively they can inhibit apoptotic events, if the cells have also suered mitochondrial damage sucient to permanently impair respiration. Because of emerging recognition of the bewildering diversity of cellular death paradigms, the relative importance of mitochondrial electron transport defects, MPT, cytochrome c leakage and other non-mitochondrial factors during ischemic injury in vivo needs to be determined individually for dierent cell types and organs.
